Preclinical H5 mRNA vaccine immunizes and prevents mortality
June 7, 2024
A preclinical trial in mice and ferrets of an experimental mRNA vaccine against the H5 highly pathogenic avian influenza (HPAI) virus generated neutralizing antibodies and prevented severe illness and mortality of the animals.